PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology

PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology

GOLDEN -- PharmaJet announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova... Read More

Wednesday May 20, 2020 0 comments Tags: Golden, PharmaJet, Abnova, Chris Cappello, COVID-19

PharmaJet appoints Chris Cappello new CEO

PharmaJet appoints Chris Cappello new CEO

GOLDEN -- PharmaJet today announced the appointment of Chris Cappello to president and CEO. Cappelllo replaces Ron Lowy , who was appointed executive chair of the companys board of directors.... Read More

Wednesday April 29, 2020 0 comments Tags: Golden, PharmaJet, Chris Cappello, Ron Lowy

PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 vaccine

PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 vaccine

GOLDEN -- PharmaJet , maker of needle-free injection technology, announced its TropisNeedle-free injection system will be used to deliver a COVID-19 vaccine being developed by Immunomic Therapeutics,... Read More

Wednesday April 15, 2020 0 comments Tags: Golden, PharmaJet, Chris Cappello, COVID-19

PharmaJet receives $9.6M award to support next-gen needle-free devices

PharmaJet receives $9.6M award to support next-gen needle-free devices

GOLDEN -- PharmaJet , maker of innovative, needle-free injection technology, announced it received a $9.6 million contract award from the Joint Science and Technology Office of the U.S. Defense... Read More

Wednesday March 18, 2020 0 comments Tags: Golden, PharmaJet, Chris Cappello